Prelude Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,500
Closed -$93K 1699
2020
Q3
$93K Buy
+2,500
New +$94.9K ﹤0.01% 931
2020
Q2
Sell
-200
Closed -$6K 2144
2020
Q1
$6K Sell
200
-49,800
-100% -$2.21M ﹤0.01% 1211
2019
Q4
$2.55M Hold
50,000
0.1% 161
2019
Q3
$2.36M Hold
50,000
0.11% 157
2019
Q2
$2.48M Hold
50,000
0.12% 146
2019
Q1
$2.13M Buy
50,000
+30,000
+150% +$1.33M 0.12% 171
2018
Q4
$821K Buy
+20,000
New +$858K 0.06% 361
2018
Q1
Sell
-4,900
Closed -$248K 1639
2017
Q4
$248K Buy
+4,900
New +$258K 0.02% 570

Other funds holding MET

Prelude Capital Management's MET Position: Q1 2026 in Review

Prelude Capital Management sold out of MetLife (MET) in Q1 2026, closing a stake of 9,672 shares — an estimated $764K sold.

Prelude Capital Management first reported a position in MET in Q1 2014 and held it in 25 quarters. The position peaked at $2.22M in Q2 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Prelude Capital Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 9,672 MetLife shares in Q1 2026, an estimated $764K.
  • Prelude Capital Management first reported a position in MetLife in Q1 2014 and held it in 25 quarters.
  • Prelude Capital Management's MetLife position peaked at $2.22M in Q2 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.